This bill establishes the Maryland Advanced Manufacturing Grant Program within the Maryland Technology Development Corporation to support companies specializing in regenerative medicine and other advanced manufacturing sectors. The program will provide grants that recipients can use exclusively for acquiring or renovating manufacturing space, improving infrastructure, and purchasing necessary equipment. A dedicated fund will be created to hold grant money, with interest earnings credited back to the fund rather than the state's general fund. The Corporation will work with the Maryland Stem Cell Research Commission to set eligibility criteria, application procedures, and award amounts, with the program taking effect on July 1, 2026.
HB 1372 requires the Maryland Health Care Commission, working with the Office of Health Care Quality, to create a process for publishing health facility inspection data (including inspection dates, quality ratings, next inspection dates, and compliance statements) on a public website. It establishes the Maryland Department of Health Centralization Commission, composed of legislators, department officials, and health board leaders, to advise on improving efficiency between the Department and health occupations boards. The bill also mandates that all health occupations boards meet minimum cybersecurity standards set by the Secretary of Information Technology. These changes directly affect health care facilities subject to inspections, health occupations boards, and the Maryland Department of Health.
HB 423 requires Prince George’s County public high schools to provide free drink spiking detection products (for GHB/ketamine) and fentanyl detection strips to all students starting the 2026-2027 school year. These products must be available at no cost in school health clinics or libraries. Each school must also report annually (by October 1) to Maryland’s Office of Overdose Response the quantity distributed during the prior school year. The bill applies exclusively to Prince George’s County schools and takes effect July 1, 2026.
SB 555 establishes the Dementia Services and Brain Health Program within the Maryland Department of Health to lead state public health efforts for brain health and dementia care. The bill shifts responsibilities from a "Director" position to this new Program, requiring it to staff the Virginia I. Jones Alzheimer’s Council, oversee implementation of the State Plan on dementia, and develop a clinical toolkit for healthcare providers. The toolkit will provide evidence-based guidance to help providers deliver person-centered dementia care across medical settings. This bill directly affects Maryland residents living with dementia or at risk, healthcare providers who will use the toolkit, and the Council’s operations.
HB 1109 creates the Maryland Medical Reserve Corps, a statewide volunteer network for emergencies like disease outbreaks or disasters, managed by the Maryland Department of Health. It requires the Department to notify county health officers about procurement opportunities for electronic health records systems, allowing counties to join without state approval if fully funded locally. The bill establishes a Public Health Workforce Development Fund (using interest earnings and transfers from another fund) and mandates the Department of Legislative Services to assess health equity impacts of new legislation. These changes directly affect county health departments, the Department of Health, and public health workforce planning.
HB 1284 allows residential service agencies providing private duty nursing to hire licensed nurses who lack full clinical experience requirements, under specific conditions. Agencies must provide approved on-site training programs, ensure clinical supervision by a qualified registered nurse, and conduct documented competency evaluations for these nurses. The bill requires agencies to maintain records of training completion and annual or disciplinary competency assessments. This directly affects private duty nursing agencies and nurses who may not meet standard clinical experience thresholds, while maintaining existing licensing and scope-of-practice standards.
HB 1377 establishes a 18-month pilot program to redirect unused, unopened prescription drugs to a state repository program. It requires participating pharmacies (repositories) to collect eligible medications during National Prescription Drug Take Back Days, package them properly, and transfer them to designated drop-off sites for distribution to eligible patients - while sending controlled substances directly to the DEA. The program aims to expand medication access for underserved communities, reduce pharmaceutical waste, and ensure drug safety through collaboration between Maryland’s Secretary of Health and the federal DEA. The pilot runs from July 2026 through December 2027, with mandatory reporting on collected medications by October 1, 2027.
HB 1367 establishes a Commission on Re-Imagining Health Care in Maryland to study and recommend changes for a new statewide healthcare system. The commission, composed of 20 appointed members including state officials, healthcare providers, insurers, county representatives, and community members, will examine how healthcare is delivered in other regions and address issues like provider shortages, cost balancing, and system integration. It will specifically study how to create a patient-centered system covering all health needs, eliminate access barriers, and ensure financial sustainability for all Maryland residents. The commission’s final recommendations, due by 2028, would guide potential future policy changes but do not enact any immediate healthcare reforms.
HB 1376 requires Maryland's Medicaid (Maryland Medical Assistance Program) and Children's Health Program to provide a review within 3 business days for transfer requests to special pediatric hospitals when requested by the hospital or referring provider. It mandates retrospective reviews if a transfer is denied as "not medically necessary," with providers reimbursed for "administrative days" (days a patient remains without transfer) during the review process. The bill directly affects special pediatric hospitals - facilities serving children under 22 or those 2+ years old with co-occurring physical/behavioral health conditions - and their referring providers. Key provisions include eliminating prior authorization requirements for transfers while establishing strict timelines and reimbursement for administrative delays during appeals. This bill updates existing Medicaid and insurance rules to streamline transfers to specialized pediatric care facilities.
This bill prohibits insurers, nonprofit health plans, and health maintenance organizations from denying emergency room coverage solely because a patient did not experience a diagnosed emergency medical condition. It requires two key studies: one to quantify hospital and post-acute care bed capacity across Maryland, and another to identify ways to improve transitions from emergency to post-acute care settings. These provisions directly affect patients receiving emergency care and healthcare providers treating them, ensuring coverage isn't denied based on diagnosis alone. The studies aim to inform data-driven recommendations for future policy improvements in emergency and post-acute care access.
